肿瘤坏死因子-α水平与连续流左心室辅助装置患者非手术出血的关系
该研究探讨连续流左心室辅助装置(LVAD)患者中肿瘤坏死因子-α(TNF-α)升高与血管生成异常及非手术出血(NSB)的机制。体外实验显示LVAD患者血清TNF-α升高,抑制周细胞Ang-1表达并诱导周细胞死亡,促进内皮细胞组织因子(TF)表达和管腔形成,TNF-α阻断可逆转这些效应。高TNF-α水平与NSB风险增加相关。
要点
- LVAD患者血清TNF-α水平升高,与NSB风险增加相关。
- TNF-α可抑制周细胞Ang-1表达并诱导周细胞死亡。
- TNF-α阻断可逆转LVAD血清诱导的内皮TF表达和血管生成异常。
核心结论
- LVAD患者中升高的TNF-α是血管生成改变、周细胞凋亡以及TF和Ang-1表达的核心调节因子。
研究设计与样本
- 体外实验:将培养的周细胞与心力衰竭、LVAD或原位心脏移植患者的血清共孵育,并设TNF-α阻断组。
- 检测周细胞Ang-1表达(RT-PCR)和细胞死亡(荧光法),内皮细胞TF表达(RT-PCR)及患者内皮活检样本TF表达(免疫荧光),Matrigel管腔形成实验。
主要发现
- LVAD患者血清TNF-α水平高于无LVAD患者,且抑制周细胞Ang-1表达并诱导周细胞死亡。
- LVAD患者血浆和内皮细胞中TF表达均升高,其血浆可诱导更多内皮TF表达。
- LVAD患者血清加速内皮管腔形成,所有效应可被TNF-α阻断逆转或减轻。
- 高TNF-α水平与NSB风险增加相关。
临床怎么用
- TNF-α可能作为LVAD患者NSB风险的生物标志物和潜在治疗靶点。
- TNF-α阻断或可改善LVAD患者血管稳定性,但需临床研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Non-surgical bleeding (NSB) due to angiodysplasia is common in left ventricular assist device (LVAD) patients. Thrombin-induced angiopoietin-2 (Ang-2) expression in LVAD patients leads to altered angiogenesis and is associated with lower angiopoietin-1 (Ang-1) and increased NSB. However, the mechanism for decreased Ang-1, made by pericytes, is unknown and the origin of thrombin in LVAD patients is unclear. We hypothesized that high tumor necrosis factor-α (TNF-α) levels in LVAD patients induce pericyte apoptosis, tissue factor (TF) expression and vascular instability. METHODS: We incubated cultured pericytes with serum from patients with heart failure (HF), LVAD or orthotopic heart transplantation (OHT), with or without TNF-α blockade. We performed several measurements: Ang-1 expression was assessed by reverse transcript-polymerase chain reaction (RT-PCR) and pericyte death fluorescently; TF expression was assessed by RT-PCR in cultured endothelial cells incubated with patient plasma with or without TNF-α blockade; and TF expression was assessed in endothelial biopsy samples from these patients by immunofluorescence. We incubated cultured endothelial cells on Matrigel with patient serum with or without TNF-α blockade and determined tube formation by microscopy. RESULTS: Serum from LVAD patients had higher levels of TNF-α, suppressed Ang-1 expression in pericytes, and induced pericyte death, and there was accelerated endothelial tube formation compared with serum from patients without LVADs. TF was higher in both plasma and endothelial cells from LVAD patients, and plasma from LVAD patients induced more endothelial TF expression. All of these effects were reversed or reduced with TNF-α blockade. High levels of TNF-α were associated with increased risk of NSB. CONCLUSIONS: Elevated TNF-α in LVAD patients is a central regulator of altered angiogenesis, pericyte apoptosis and expression of TF and Ang-1.
引用
- Tabit CE, Coplan MJ, Chen P, et al. Tumor necrosis factor-α levels and non-surgical bleeding in continuous-flow left ventricular assist devices. J Heart Lung Transplant. 2017. PMID: 28651907. doi:10.1016/j.healun.2017.06.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。